Publications by authors named "Rosa Grisanti"

Introduction: Stimulation in the right ventricular outflow tract (RVOT) showed better clinical and hemodynamic results at short, medium and long term than apical pacing.

Methods: We enrolled 30 patients undergoing pacemaker implantation with positioning of electrocatheters in the high or low RVOT. All patients underwent clinical, echocardiographic and electrocardiographic evaluation after implantation and at 6-month follow-up.

View Article and Find Full Text PDF

Subjects with peripheral arterial disease (PAD) of the lower limbs are at high risk for cardiovascular and cerebrovascular events and the prevalence of coronary artery disease in such patients is elevated. Recent studies have shown that regular use of cardiovascular medications, such as therapeutic and preventive agents for PAD patients, seems to be promising in reducing long-term mortality and morbidity. The angiotensin-converting-enzyme (ACE) system plays an important role in the pathogenesis and progression of atherosclerosis, and ACE-inhibitors (ACE-I) seem to have vasculoprotective and antiproliferative effects as well as a direct anti-atherogenic effect.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Rosa Grisanti"

  • - Rosa Grisanti's research primarily focuses on cardiovascular health, particularly the effects of various pacing techniques on heart function and the role of medications in managing peripheral artery disease (PAD).
  • - In her 2015 study, she found that stimulation in the right ventricular outflow tract (RVOT) provided superior clinical and hemodynamic outcomes compared to traditional apical pacing in patients with pacemakers.
  • - In a 2009 article, Grisanti discussed the importance of ACE-inhibitors in the management of PAD, highlighting their potential vasculoprotective and anti-atherogenic properties, which could be beneficial in reducing long-term cardiovascular risks in affected patients.